News Releases Keyword Search Year None2019201820172016 Jun-20-2016 Oncternal Receives Fast Track Designation for TK216 in Relapsed or Refractory Ewing Sarcoma Jun-01-2016 Oncternal Merges with Tokalas to Form Clinical-Stage Biotech Company w/ Promising Oncology Pipeline Apr-12-2016 Oncternal Awarded Exclusive Worldwide License to ROR1 Antibody and Related Programs from UCSD Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4
